Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1960 1
1962 2
1964 4
1965 4
1966 5
1967 3
1968 9
1969 4
1970 8
1971 7
1972 15
1973 17
1974 24
1975 21
1976 15
1977 14
1978 18
1979 18
1980 11
1981 30
1982 5
1983 23
1984 20
1985 27
1986 28
1987 28
1988 23
1989 28
1990 25
1991 26
1992 40
1993 45
1994 39
1995 32
1996 27
1997 22
1998 30
1999 55
2000 45
2001 44
2002 48
2003 68
2004 71
2005 62
2006 49
2007 46
2008 42
2009 56
2010 64
2011 77
2012 83
2013 62
2014 54
2015 65
2016 77
2017 72
2018 94
2019 78
2020 100
2021 114
2022 71
Text availability
Article attribute
Article type
Publication date

Search Results

2,105 results
Results by year
Filters applied: . Clear all
Page 1
Mucus sialylation determines intestinal host-commensal homeostasis.
Yao Y, Kim G, Shafer S, Chen Z, Kubo S, Ji Y, Luo J, Yang W, Perner SP, Kanellopoulou C, Park AY, Jiang P, Li J, Baris S, Aydiner EK, Ertem D, Mulder DJ, Warner N, Griffiths AM, Topf-Olivestone C, Kori M, Werner L, Ouahed J, Field M, Liu C, Schwarz B, Bosio CM, Ganesan S, Song J, Urlaub H, Oellerich T, Malaker SA, Zheng L, Bertozzi CR, Zhang Y, Matthews H, Montgomery W, Shih HY, Jiang J, Jones M, Baras A, Shuldiner A, Gonzaga-Jauregui C, Snapper SB, Muise AM, Shouval DS, Ozen A, Pan KT, Wu C, Lenardo MJ. Yao Y, et al. Among authors: kubo s. Cell. 2022 Mar 31;185(7):1172-1188.e28. doi: 10.1016/j.cell.2022.02.013. Epub 2022 Mar 17. Cell. 2022. PMID: 35303419
Suppression of autophagic activity by Rubicon is a signature of aging.
Nakamura S, Oba M, Suzuki M, Takahashi A, Yamamuro T, Fujiwara M, Ikenaka K, Minami S, Tabata N, Yamamoto K, Kubo S, Tokumura A, Akamatsu K, Miyazaki Y, Kawabata T, Hamasaki M, Fukui K, Sango K, Watanabe Y, Takabatake Y, Kitajima TS, Okada Y, Mochizuki H, Isaka Y, Antebi A, Yoshimori T. Nakamura S, et al. Among authors: kubo s. Nat Commun. 2019 Feb 19;10(1):847. doi: 10.1038/s41467-019-08729-6. Nat Commun. 2019. PMID: 30783089 Free PMC article.
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update.
Kokudo N, Takemura N, Hasegawa K, Takayama T, Kubo S, Shimada M, Nagano H, Hatano E, Izumi N, Kaneko S, Kudo M, Iijima H, Genda T, Tateishi R, Torimura T, Igaki H, Kobayashi S, Sakurai H, Murakami T, Watadani T, Matsuyama Y. Kokudo N, et al. Among authors: kubo s. Hepatol Res. 2019 Oct;49(10):1109-1113. doi: 10.1111/hepr.13411. Epub 2019 Sep 6. Hepatol Res. 2019. PMID: 31336394
Efficacy and safety of tofacitinib versus baricitinib in patients with rheumatoid arthritis in real clinical practice: analyses with propensity score-based inverse probability of treatment weighting.
Miyazaki Y, Nakano K, Nakayamada S, Kubo S, Inoue Y, Fujino Y, Tanaka Y. Miyazaki Y, et al. Among authors: kubo s. Ann Rheum Dis. 2021 Sep;80(9):1130-1136. doi: 10.1136/annrheumdis-2020-219699. Epub 2021 Apr 7. Ann Rheum Dis. 2021. PMID: 33827788 Free PMC article.
Immunophenotype involved in IgG4-related disease.
Kubo S, Nakayamada S, Tanaka Y. Kubo S, et al. Mod Rheumatol. 2019 Mar;29(2):226-230. doi: 10.1080/14397595.2018.1537962. Epub 2019 Jan 9. Mod Rheumatol. 2019. PMID: 30334637 Free article. Review.
Baricitinib for the treatment of rheumatoid arthritis.
Kubo S, Nakayamada S, Tanaka Y. Kubo S, et al. Expert Rev Clin Immunol. 2016 Sep;12(9):911-9. doi: 10.1080/1744666X.2016.1214576. Epub 2016 Aug 5. Expert Rev Clin Immunol. 2016. PMID: 27427830 Review.
Portal Vein Embolization: History and Current Indications.
Shinkawa H, Takemura S, Tanaka S, Kubo S. Shinkawa H, et al. Among authors: kubo s. Visc Med. 2017 Dec;33(6):414-417. doi: 10.1159/000479474. Epub 2017 Nov 22. Visc Med. 2017. PMID: 29344514 Free PMC article. Review.
2,105 results